insights_auto
Outlook: 28.2% bullish·23.5% bearish
Go to analysischevron_right
MRNA:NASDAQ
Moderna Inc
215,19 $
arrow_upward
+0,68%(+1,45) 1D
13 հոկ, 15:25:25 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MRNA...
Open
207,63 $
High
218,48 $
Low
204,70 $
Mkt. cap
85,91 մլրդ
Avg. vol.
16,58 մլն
Volume
10,26 մլն
52-wk high
227,44 $
52-wk low
22,29 $
EPS
-7,98 $
Beta
1,09
Shares outstanding
399,24 մլն
No. of employees
5 հզր
Open
207,63 $
High
218,48 $
Low
204,70 $
Mkt. cap
85,91 մլրդ
Avg. vol.
16,58 մլն
Volume
10,26 մլն
52-wk high
227,44 $
52-wk low
22,29 $
EPS
-7,98 $
Beta
1,09
Shares outstanding
399,24 մլն
No. of employees
5 հզր
News stories
From web sources and news partners
MarketBeat
·
1 ժամ առաջ
Sivik Global Healthcare LLC Makes New Investment in Moderna, Inc. $MRNA
Benzinga
·
1 ժամ առաջ
10 Health Care Stocks With Whale Alerts In Today’s Session
Zacks
·
3 ժամ առաջ
MRNA Stock Gains Over $4B in a Week: Time to Buy, Hold or Sell?
ad-hoc-news.de
·
4 ժամ առաջ
Average target for Moderna stock rises to USD 118.42
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
About Moderna Inc